🩺 The Silent Threat in Cardiac Surgery: Are We Doing Enough to Stop Surgical Site Infections (SSIs) — and Antimicrobial Resistance (AMR)?
⚠️ AMR: The New Danger Lurking Behind Every Surgery Today, 8 out of 10 patients coming for elective surgeries already harbour drug-resistant bacteria. This forces surgeons to use reserved, very expensive, last-line antibiotics just to prevent or treat infections that were once easily manageable. Antimicrobial resistance (AMR) is not a future threat — it’s here, […]
Surgical Treatment of Hypertrophic Cardiomyopathy
By Dr. Hemant Pathare 🔬 Understanding Hypertrophic Cardiomyopathy (HCM) Hypertrophic Cardiomyopathy (HCM) is a genetic heart disease characterized by abnormal thickening of the ventricular septum. This thickening can obstruct blood flow from the heart. â—Ź Prevalence: Approximately 1 in 200–500 adults â—Ź Key Symptoms: â—‹Shortness of breath (Dyspnea) â—‹Chest pain â—‹Palpitations â—‹Syncope (fainting) â—‹Increased risk […]
Beyond the Heart-Lung Machine: Matching the coronary artery bypass procedure to the patient.
đź“– Introduction Heart disease remains one the number one leading cause of death worldwide, and Coronary Artery Bypass Grafting (CABG) continues to be one of the most effective and commonly performed treatments for patients with severe coronary artery disease. Over the decades, advances in surgical techniques have significantly improved outcomes, recovery, and patient safety. One […]
